Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giuseppina Bruno
Observed name:
Bruno, Giuseppina
Institutions:
University of Foggia,
Ospedali Riuniti di Foggia
Observed institutions:
University of Foggia,
University of Salerno,
University of Campania "Luigi Vanvitelli",
Ospedali Riuniti di Foggia
ORCID:
0000-0002-7065-9850
Observed ORCID:
0000-0002-7065-9850
OpenAlex ID:
A5073176208
The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading
2017
·
Roberta Tarallo
, Giorgio Giurato
, et al.
·
Genome biology
·
79
PDF
Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy
2015
·
Stefania Catalano
, Antonella Campana
, et al.
·
Clinical Cancer Research
·
68
PDF
Small non-coding RNA deregulation in endometrial carcinogenesis
2015
·
Maria Ravo
, Angela Cordella
, et al.
·
Oncotarget
·
61
PDF
Activation of Farnesoid X Receptor impairs the tumor-promoting function of breast cancer-associated fibroblasts
2018
·
Ines Barone
, Valentina Vircillo
, et al.
·
Cancer Letters
·
38
IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives
2020
·
Fabiana Crispo
, Michele Pietrafesa
, et al.
·
Molecules
·
33
PDF
Circulating Tumor DNA: A New Research Frontier in Urological Oncology from Localized to Metastatic Disease
2024
·
Marianna Garofoli
, Brigida Anna Maiorano
, et al.
·
European Urology Oncology
·
29
PDF
TRAP1 modulates mitochondrial biogenesis via PGC-1α/TFAM signalling pathway in colorectal cancer cells
2024
·
Giuseppina Bruno
, Michele Pietrafesa
, et al.
·
Journal of Molecular Medicine
·
24
PDF
TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation
2022
·
Giuseppina Bruno
, Valeria Li Bergolis
, et al.
·
International Journal of Oncology
·
22
PDF
Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era
2021
·
Guido Giordano
, Pietro Parcesepe
, et al.
·
International Journal of Molecular Sciences
·
19
PDF
Androgen receptor, PARP signaling, and tumor microenvironment: the ‘perfect triad’ in prostate cancer?
2024
·
Marianna Garofoli
, Brigida Anna Maiorano
, et al.
·
Therapeutic Advances in Medical Oncology
·
16
Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma
2021
·
Donato Lacedonia
, Matteo Landriscina
, et al.
·
Journal of Oncology
·
15
PDF
Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer
2023
·
Guido Giordano
, Raffaele Ivan Cincione
, et al.
·
The Oncologist
·
12
PDF
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care
2024
·
Vincenza Conteduca
, Piergiorgio Di Tullio
, et al.
·
Prostate Cancer and Prostatic Diseases
·
8
MiRNA expression affects survival in patients with obstructive sleep apnea and metastatic colorectal cancer
2024
·
Piera Soccio
, Giorgia Moriondo
, et al.
·
Non-coding RNA Research
·
7
Real-World Outcomes and Molecular Profiling for Patients with Metastatic Castration-resistant Prostate Cancer with Lung Metastases: A Long-term Multicenter Experience
2025
·
Giuseppina Bruno
, Maria Iole Natalicchio
, et al.
·
European Urology Oncology
·
3
PDF
Reconciling Clinical and Molecular Heterogeneity in Metastatic Castration-resistant Prostate Cancer: The Promise of Integrated Prognostic Models
2025
·
Vincenza Conteduca
, Giuseppina Bruno
, et al.
·
European Urology
·
1
Corrigendum to “MiRNA expression affects survival in patients with obstructive sleep apnea and metastatic colorectal cancer” [Non-coding RNA research 10 (2025) 91–97]
2024
·
Piera Soccio
, Giorgia Moriondo
, et al.
·
Non-coding RNA Research
·
1
Differential and divergent activity of insulin‑like growth factor binding protein 6 in platinum‑sensitive versus platinum‑resistant high‑grade serous ovarian carcinoma cell lines
2022
·
Annamaria Piscazzi
, Valentina Condelli
, et al.
·
Oncology Letters
·
1
PDF
Targeting Breast Cancer-associated Fibroblasts with Farnesoid X Receptor Ligands as a Novel Treatyment Strategy for Breast Cancer.
2016
·
Ines Barone
, Vircillo
, et al.
·
Archive of Doctoral Theses and Digital Collections (University of Calabria)
·
1
Prognostic impact of variants of uncertain significance (VUS) in BRCA genes and homologous recombination repair (HRR) genes in prostate cancer: a real-world multicenter study
2026
·
Marianna Garofoli
, Maria Iole Natalicchio
, et al.
·
BMC Medicine
Serum [‐2]proPSA as a Candidate Phenotypic Correlate of Molecular Alterations and Prognostic Marker in Metastatic Castration‐Resistant Prostate Cancer
2026
·
Vincenza Conteduca
, Marianna Garofoli
, et al.
·
Prostate Cancer
PDF
Supplementary Materials and Methods from Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy
2023
·
Stefania Catalano
, Antonella Campana
, et al.
Supplementary Figure 1 from Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy
2023
·
Stefania Catalano
, Antonella Campana
, et al.
Supplementary Figure 2 from Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy
2023
·
Stefania Catalano
, Antonella Campana
, et al.
Supplementary Table 1 from Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy
2023
·
Stefania Catalano
, Antonella Campana
, et al.
Show more works
View as search
Works count:
50
Citation count:
438
H-index:
12
I10-index:
12
Year
Topic
Type